Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/13728
Title: Is Aerosolized Pentamidine for Pneumocystis Pneumonia Prophylaxis in Renal Transplant Recipients Not as Safe as We Might Think?
Austin Authors: Macesic, Nenad;Urbancic, Karen F ;Ierino, F;Grayson, M Lindsay 
Affiliation: Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia
Division of Infectious Diseases, Columbia University Medical Center
Department of Nephrology, Austin Health, Heidelberg, Victoria, Australia
Department of Medicine, University of Melbourne
Issue Date: Apr-2016
metadata.dc.date: 2016-01-11
Publication information: Antimicrobal Agents and Chemotherapy 2016; 60(4): 2502-2504
Abstract: Outbreaks of Pneumocystis pneumonia have been described in renal transplant recipients. Aerosolized pentamidine is frequently used for prophylaxis in this setting. We report our experience of aerosolized pentamidine use in 56 renal transplant recipients and find high rates of adverse reactions in patients with chronic respiratory disease.
URI: http://ahro.austin.org.au/austinjspui/handle/1/13728
DOI: 10.1128/AAC.02290-15
PubMed URL: 26824946
Type: Journal Article
Subjects: Pneumocystis
Pneumonia
Kidney Transplantation
Appears in Collections:Journal articles

Show full item record

Page view(s)

2
checked on Apr 17, 2021

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.